Science to transform lives
Immunocore is a pioneering, clinical-stage T cell receptor biotechnology company working to develop and commercialize a new generation of transformative medicines to address unmet needs in cancer, infection and autoimmune disease.
Contact Information
Media
Sebastien Desprez, Head of Communications
T: +44 (0) 7458030732
E: Sebastien.Desprez@immunocore.com
Investor Relations
Clayton Robertson, Head of Investor Relations
T: +1 (215) 384-4781
E: ir@immunocore.com
Presentation
